Heart attacks in women go largely unrecognized 30 to 55 percent of the time and those who miss the warning signs and fail or delay getting help, run the risk of death or grave disability. But researchers at Binghamton University and SUNY Upstate Medical University have developed an educational program they believe will shorten the time to treatment and ultimately, save lives. Women often don't have the same kind of chest pains that men generally experience during a heart attack. They may also have a range of other symptoms, not all of them easy for the typical sufferer to identify and so in many cases, they tend to just ignore the warning signs. In hopes of shortening women's time to treatment, Pamela Stewart Fahs, professor and Decker Chair in Rural Nursing at Binghamton University's Decker School of Nursing, is collaborating with Melanie Kalman, associate professor and director of research, and Margaret Wells, assistant professor, in the College of Nursing at SUNY Upstate Medical University, on a project called "Matters of â Your Heart.
New research published online in the FASEB Journal suggests that the types and levels of bacteria in the intestines may be used to predict a person's likelihood of having a heart attack, and that manipulating these organisms may help reduce heart attack risk. This discovery may lead to new diagnostic tests and therapies that physicians use to prevent and treat heart attacks. In addition, this research suggests that probiotics may be able to protect the heart in patients undergoing heart surgery and angioplasty. "Our discovery is a revolutionary milestone in the prevention and treatment of heart attacks, " said John E. Baker, Ph.D., study author from the Division of Cardiothoracic Surgery at the Medical College of Wisconsin in Milwaukee. "The biochemical link between intestinal bacteria, their metabolites, and injury to the heart will reduce the risk of death from a heart attack and, coupled with the use of probiotics, will ultimately be able to improve the overall cardiovascular health of the human population.
Leading Medical Groups Collaborate To Ensure Consistent, Responsible Uptake Of Transcatheter Aortic Valve Replacement
With the U.S. Food and Drug Administration's recent approval of transcatheter aortic valve replacement (TAVR) for patients with aortic valvular stenosis, the American College of Cardiology Foundation (ACCF), along with the American Association for Thoracic Surgery (AATS), the Society for Cardiovascular Angiography and Interventions (SCAI) and the Society of Thoracic Surgeons (STS), today released an expert consensus document to provide important guidance on its use. Aortic valvular stenosis - or aortic stenosis (AS) - occurs when the heart's aortic valve narrows, making it difficult for the heart to pump blood through the body. Until recently, some patients with severe AS who were at very high risk for conventional surgical aortic valve replacement had few, if any, options for treatment to help prevent serious heart problems including heart failure and death.
A new study that analyzes 10 years of data finds that contrary to what many people may believe, taking part in marathons and half-marathons is not linked to higher risk of cardiac arrest compared to other forms of athletics. The study, published online on 12 January in the New England Journal of Medicine, reveals that most of the participants who did experience cardiac arrest during such long-distance races had undiagnosed, pre-existing heart problems. The researchers, who sourced their data from a US registry of cardiac arrests during marathons and half-marathons, also found that a key factor in saving the lives of such victims was the ability of bystanders to start CPR. Senior author Dr Aaron Baggish, director of the Cardiovascular Performance Program in the Cardiology division of Massachusetts General Hospital (MGH), and colleagues found that the rate of cardiac arrest in marathons and half-marathons was the same as or lower than that for other strenuous physical activities, that male contestants accounted for most of them and appear to be at most risk.
Observational epidemiologic studies relating wine and alcohol to health all suffer from the fact that they, of necessity, compare people who prefer certain beverages, but not the beverages themselves. While there have been many intervention trials in animals, randomized trials in humans are less common. Randomized crossover trials, in which each subject receives all interventions in sequence, can be especially important as they tend to avoid baseline differences among subjects and can detect effects of different interventions with smaller numbers of subjects. This study by Chiva-Blanch G et al, just published in the American Journal of Clinical Nutrition, included 67 male volunteers in Spain who were considered to be at "high-risk" of cardiovascular disease on the basis of increased BMI, smoking, diabetes, hypertension, or other risk factors.